genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Supplement
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
Tech Exclusives
GE Healthcare, NIBRT Partner on Cell Therapy, Single-Use Bioprocessing
News
CRISPR Anticancer Tech Aids Immune System Surveillance and Attack
Natural Products
Coffee Extracts Improve Insulin Sensitivity
Neuroscience
Cannabis During Pregnancy Alters Offspring’s Brain in Rats
News
Sweet-Talking Slime Mollifies Pathogens
Insights
Commentary
Successfully Addressing the Challenges of Glycosylation
Brexit
Top 10 European Biopharma Clusters
Tech Exclusives
One-Stop-Shop Genome Editing Product Launched by Inscripta
October 2019 Vol. 39 No. 10
Better Living through Molecular Neuropharmacology
October 2019 Vol. 39 No. 10
CRISPR Dx May Help Nix Disease
A-Lists
Brexit
Top 10 European Biopharma Clusters
Insights
Top 10 U.S. Biopharma Clusters
Insights
10 Takeover Targets to Watch This Fall
Insights
What the Top 10 Biopharma CEOs Are Making
October 2019 Vol. 39 No. 10
Top 10 Companies Leveraging Gene Editing in 2019
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Tech Exclusives
GE Healthcare, NIBRT Partner on Cell Therapy, Single-Use Bioprocessing
News
Sweet-Talking Slime Mollifies Pathogens
Five Prime Therapeutics
Five Prime Eliminates 70 Jobs in Restructuring
News
CRISPR-Cas13 Developed as Combination Antiviral and Diagnostic System
Magazine
All
Supplement
October 2019 Vol. 39 No. 10
Better Living through Molecular Neuropharmacology
October 2019 Vol. 39 No. 10
CRISPR Dx May Help Nix Disease
Tech Exclusives
Modular Bioprocessing Makes Adaptability a Snap
Tech Exclusives
A Nanomedicine Technology Sampler Pack
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Upcoming Webinars
A Cultured Life: Innovations in Spheroid and Organoid Models
Posters
Microfluidic Diffusional Sizing: A Novel Method for Characterizing Protein Interactions
Drug Discovery
Importance of mAb Discovery and Development in Immunotherapy
eBooks
Sample Preparation for Quality Control: Solutions for Optimized Workflows and Accurate…
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Home
Antibodies
Bispecific Antibodies
Bispecific Antibodies
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Bispecific Antibodies
Genmab Partners on Cancer Antibodies with BliNK Biomedical, Launches $503M U.S. IPO
Bispecific Antibodies
Recent Advances and the Future of Antibody Engineering
Bispecific Antibodies
AbbVie to Co-Develop Teneobio’s Lead Candidate for Multiple Myeloma, Gains Acquisition Option
Bispecific Antibodies
Sanofi to Develop Biomunex Bi-, Multi-Specific Antibodies for Immuno-Oncology and Other Areas
Bispecific Antibodies
Bispecific Playgrounds? No, Factory Floors
Bispecific Antibodies
Bispecific Antibodies Grapple with Cancer by Grabbing T Cells
Bispecific Antibodies
Daiichi Sankyo Triples Down on Immuno-Oncology Collaboration with Zymeworks
Bispecific Antibodies
Janssen to Develop Bispecific Antibodies Based on Zymeworks Platforms in Up-to-$1.4B...
Bispecific Antibodies
Bifunctional Antifungal Besets the Cell Wall, Rallies Antibodies to the Siege
Bispecific Antibodies
Celgene Ends Option to Buy Sutro, Gains Rights to I/O Candidates...
Bispecific Antibodies
Alligator, Aptevo Partner on Bispecific Cancer Immunotherapy Targeting 4-1BB
Bispecific Antibodies
F-star, Merck Agree Up to €1B Deal to Develop Five Bispecific...
Bispecific Antibodies
EpimAb Raises $25M in Series A to Progress Bispecific Antibodies into...
Bispecific Antibodies
Hanmi, Innovent Agree to Co-Develop Bispecific Anticancer Antibody
Bispecific Antibodies
Numab, Ono Ink CHF258M Deal for Multispecific Immuno-Oncology Antibody
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![The structure of the ROR1-binding arm of the bispecific antibody in complex with ROR1 was determined by X-ray crystallography. [Rader lab/The Scripps Research Institute]](https://www.genengnews.com/wp-content/uploads/2018/08/May31_2018_RaderLadScrippsInst_AntibodyBindingSite4715364246-324x160.jpg "Bispecific Antibodies Grapple with Cancer by Grabbing T Cells")
